HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-17 / Cancer 2012 Sep;118(17):4354-62Immunotherapy for metastatic colorectal cancer: present status and new options
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2012-01-03 / Scand. J. Gastroenterol. 2012 Mar;47(3):315-24The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-01-01 / Curr. Top. Microbiol. Immunol. 2012;351:181-220Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-01-01 / Cell Biochem. Biophys. 2012 Jan;62(1):91-9A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-01 / J Immunother 2012 Jan;35(1):54-65[Prostate carcinoma: vaccination as a new option for treatment]
/in Dendritic Cells, International Publications, Prostate Cancer /von 2012-01-01 / Urologe A 2012 Jan;51(1):44-9Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report
/in Dendritic Cells, International Publications, NSCLC /von 2011-12-06 / Arch. Immunol. Ther. Exp. (Warsz.) 2012 Feb;60(1):69-77Immunotherapy for glioma: getting closer to the clinical arena?
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-12-01 / Curr. Opin. Neurol. 2011 Dec;24(6):641-7Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-11-26 / Vaccine 2012 Jun;30(29):4394-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de